Skip to main content

Table 2 Demographic and laboratory data of patients with and without dyslipidemia

From: Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes

 

Dyslipidemia (n = 568)

Normo-lipidemia (n = 238)

P value

Age (years), median (range)

12.1 (2.6–18)

12 (3–17.7)

0.29

Sex

• Male

243 (42.78%)

115 (48.32 %)

0.15

• Female

325 (57.22 %)

123 (51.68 %)

Age of diabetes onset (years), median (range)

6.1 (1–15)

6 (1–15.1)

0.75

Diabetes duration (years), median (range)

5 (1–17)

5 (1–15)

0.08

Insulin dose (U/kg/day), mean ± SD

1.1 ± 0.7

1.2 ± 0.67

0.06

Weight SDS, mean ± SD

− 0.7 ± 1.4

− 0.89 ± 1.3

0.07

Height SDS, mean ± SD

− 1.53 ± 1.6

− 1.62 ± 1.4

0.45

BMI SDS, mean ± SD

− 0.56 ± 1

− 0.7 ± 1.2

0.08

TC (mg/dl), mean ± SD

167.96 ± 75.8

128.75 ± 29.71

< 0.001*

TG (mg/dl), mean ± SD

90.24 ± 41.42

68.5 ± 23.25

< 0.001*

LDL (mg/dl), mean ± SD

107.69 ± 31.81

73.94 ± 16.87

< 0.001*

HDL (mg/dl), mean ± SD

48.59 ± 18.45

59.53 ± 15.1

< 0.001*

HbA1c (%), mean ± SD

8.79 ± 1.77

8.62 ± 1.83

0.22

Glycemic control

 Poor

425

167

0.17

 Good

143

71

  1. *P value < 0.05 is considered significant, TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, HDL high-density lipoprotein, HbA1c glycosylated hemoglobin, BMI body mass index, SDS standard deviation score